Merck & Co Inc (MRK) Highlights Gaps in Flea and Tick Prevention Adherence
ByAinvest
Wednesday, Aug 20, 2025 4:50 am ET1min read
MRK--
A recent survey conducted by Merck & Co. Inc. has revealed significant gaps in pet owner adherence to flea and tick prevention, highlighting the need for improved compliance and education. Despite 83% of pet owners considering flea and tick treatment crucial, 46% of dog owners and 51% of cat owners have forgotten to administer treatment in the past year. This non-compliance is a concern for veterinarians, who note that most pet owners do not follow year-round treatment plans [1].
The survey, titled "Pet Owner & Vet Perspectives on Parasite Treatment and Prevention: A Global Survey," involved 4,072 pet owners and 582 veterinarians in 15 countries. It found that while 80% of pet owners feel confident in administering flea and tick medication, 74% of veterinarians worry about inconsistent or incorrect medication administration. In the United States, two-thirds of veterinarians report that most pet owners do not follow year-round treatment plans [1].
Despite the challenges, there is a growing awareness of the potential threats posed by fleas and ticks. More than half of dog owners worldwide reported flea or tick issues at least once or twice, and 66% of outdoor cat owners reported the same. However, only 40% of pet owners strongly agree that fleas and ticks pose a threat to their personal health. This lack of awareness is particularly concerning in the United States, where half of pet owners see fleas and tick-borne illnesses as a potential risk to their pet or to themselves or their family [1].
To address these gaps, Merck is strategically positioned to capitalize on the growing demand for effective flea and tick prevention solutions. The survey also found that 75% of pet owners are likely to try a once-yearly medication, suggesting a potential market for long-duration prescription medications. Globally, 65% of veterinarians would be likely to recommend an annual medication option, indicating a strong preference for prescription solutions [1].
The survey underscores the importance of targeted education and awareness about the importance of year-round flea and tick prevention. Merck & Co. Inc. is well-positioned to leverage these insights to develop and promote effective prevention strategies, potentially driving growth in its animal health division.
References:
[1] https://www.businesswire.com/news/home/20250812770441/en/Vets-and-Pet-Owners-See-Gaps-in-Flea-and-Tick-Prevention-Highlighting-Need-for-Year-Round-Care-New-Merck-Animal-Health-Global-Survey-Finds
Merck & Co Inc's survey highlights significant gaps in pet owner adherence to flea and tick prevention. Despite 83% considering treatment crucial, 46% of dog owners and 51% of cat owners have forgotten to administer treatment in the past year. Veterinarians are concerned about inconsistent administration and 75% of pet owners are likely to try a once-yearly medication. Merck is strategically positioned to capitalize on the growing demand for effective flea and tick prevention solutions.
Title: Merck & Co. Inc. Survey Highlights Gaps in Pet Owner Adherence to Flea and Tick PreventionA recent survey conducted by Merck & Co. Inc. has revealed significant gaps in pet owner adherence to flea and tick prevention, highlighting the need for improved compliance and education. Despite 83% of pet owners considering flea and tick treatment crucial, 46% of dog owners and 51% of cat owners have forgotten to administer treatment in the past year. This non-compliance is a concern for veterinarians, who note that most pet owners do not follow year-round treatment plans [1].
The survey, titled "Pet Owner & Vet Perspectives on Parasite Treatment and Prevention: A Global Survey," involved 4,072 pet owners and 582 veterinarians in 15 countries. It found that while 80% of pet owners feel confident in administering flea and tick medication, 74% of veterinarians worry about inconsistent or incorrect medication administration. In the United States, two-thirds of veterinarians report that most pet owners do not follow year-round treatment plans [1].
Despite the challenges, there is a growing awareness of the potential threats posed by fleas and ticks. More than half of dog owners worldwide reported flea or tick issues at least once or twice, and 66% of outdoor cat owners reported the same. However, only 40% of pet owners strongly agree that fleas and ticks pose a threat to their personal health. This lack of awareness is particularly concerning in the United States, where half of pet owners see fleas and tick-borne illnesses as a potential risk to their pet or to themselves or their family [1].
To address these gaps, Merck is strategically positioned to capitalize on the growing demand for effective flea and tick prevention solutions. The survey also found that 75% of pet owners are likely to try a once-yearly medication, suggesting a potential market for long-duration prescription medications. Globally, 65% of veterinarians would be likely to recommend an annual medication option, indicating a strong preference for prescription solutions [1].
The survey underscores the importance of targeted education and awareness about the importance of year-round flea and tick prevention. Merck & Co. Inc. is well-positioned to leverage these insights to develop and promote effective prevention strategies, potentially driving growth in its animal health division.
References:
[1] https://www.businesswire.com/news/home/20250812770441/en/Vets-and-Pet-Owners-See-Gaps-in-Flea-and-Tick-Prevention-Highlighting-Need-for-Year-Round-Care-New-Merck-Animal-Health-Global-Survey-Finds
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet